| dc.contributor.author | Gibaldi, Milo | |
| dc.date.accessioned | 2016-03-01T00:27:49Z | |
| dc.date.available | 2016-03-01T00:27:49Z | |
| dc.date.issued | 1991 | |
| dc.identifier.citation | Gibaldi, Milo(1991). Biopharmaceutics and clinical pharmacokinetics,Unite States of America, Lea & Febiger | en_US |
| dc.identifier.isbn | 0-8121-1346-2 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/833 | |
| dc.description.abstract | Biopharmaceutics concerns the relationship
between the physical and chemical properties of a
drug in a dosage form and the pharmacologic. toxicologic,
or clinical response observed after its administration.
The study of biopharmaceulics has
been extended beyond that of a descriptive discipline
by the development of pharmacokinetics
which concerns the study and characterization of
the time course of drug absorption, distribution,
metabolism, and excretion, as well as the relationship
of these processes to the intensity and time
course of therapeutic and adverse effects of drugs.
Pharmacokinetics involves the application of mathematics
and biochemistry in a physiologic and
pharmacologic context. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Lea & Febiger | en_US |
| dc.subject | Biopharmaceutics, pharmacologic, toxicologic, therapeutic | en_US |
| dc.title | Biopharmaceutics and clinical pharmacokinetics | en_US |
| dc.type | Book | en_US |
